Depression in medical patients

Advances in Psychosomatic Medicine

Volumn 26, Issue , 2005, Pages 98-117

  Arolt, Volker ^a   Rothermundt, Matthias ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG INTERACTION; EPIDEMIOLOGY; GERMANY; HUMAN; PATIENT ATTITUDE; PATIENT CARE; PATIENT REFERRAL; PSYCHOLOGICAL ASPECT; PSYCHOSOMATIC DISORDER; REVIEW; SOMATOFORM DISORDER; STATISTICS;

ANTIDEPRESSIVE AGENTS; CAUSALITY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DRUG INTERACTIONS; GERMANY; HUMANS; PATIENT CARE TEAM; PSYCHOPHYSIOLOGIC DISORDERS; REFERRAL AND CONSULTATION; SICK ROLE; SOMATOFORM DISORDERS;

EID: 4444221207     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (102)

1. Muthny F: Krankheitsverarbeitung bei körperlichen Erkrankungen und Erfordernisse des psychosozialen Konsiliardienstes; in Arolt V, Diefenbacher A (eds): Psychiatrie in der klinischen Medizin. Darmstadt, Steinkopff, 2004, pp 100-121.
2. Freyberger H, Freyberger HJ: Supportive psychotherapy. Psychother Psychosom 1994;61:132-142.
3. König F: Psychopharamkotherapie bei somatischen Erkrankungen; in Arolt V, Diefenbacher A (eds): Psychiatrie in der klinischen Medizin. Darmstadt, Steinkopff, 2004, pp 141-159.
4. Lipsitt DL: Psychotherapy; in Wise MG, Rundell JR (eds): Textbook of Consultation Liaison Psychiatry, ed 2. Washington, American Psychiatric Press, 2002.
5. Rockland LH: Supportive Therapy: A Psychodynamic Approach. New York, Basic Books, 2003.
6. Arolt V, Fein A, Driessen M, Dorlöchter L, Maintz C: Depression and social functioning in general hospital in-patients. J Psychosom Res 1998;42:117-126.
7. Broocks A, Meyer TF, George A, Pekrun G, Hillmer-Vogel U, Hajak G, Bandelow B, Ruther E: Der Wert des Sports bei der Behandlung psychischer Störungen. Psychother Psychosom Med Psychol 1997;47:379-393.
8. Broocks A, Bandelow B, Pekrun G, George A, Meyer T, Bartmann U, Hillmer-Vogel U, Ruther E: Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry 1998;155:603-609.
9. Beutel M, Deckardt R, von Rad M, Weiner H: Grief and depression after miscarriage: Their separation, antecedents, and course. Psychosom Med 1995;57:517-526.
10. Jacobs SC: Measures of the psychological distress of bereavement; in Zisook S (ed): Biopsychosocial Aspects of Bereavement. Washington, American Psychiatric Press, 1987.
11. Kersting A, Fisch S, Baez E: Psychosocial care of mothers after stillbirth. Lancet 2002;360:1600.
12. Kersting A, Reutemann M, Ohrmann P, Schutt K, Wesselmann U, Rothermundt M, Suslow T, Arolt V: Traumatische Trauer - ein eigenständiges Krankheitsbild? Psychotherapeut 2001;46: 301-308.
13. Horowitz MJ: Stress Response Syndromes. Northvale, Aaronson, 1997.
14. Horowitz MJ, Siegel B, Holen A, Bonanno GA, Milbrath C, Stinson MD: Diagnostic criteria for complicated grief disorder. Am J Psychiatry 1997;154:904-910.
15. Prigerson HG, Bierhals AJ, Kasl MPH, Reynolds CF, Shear MK, Newsom JT, Jacobs S: Complicated grief as a disorder distinct from bereavement related depression and anxiety: A replication study. Am J Psychiatry 1996;153:84-86.
16. Prigerson HG, Frank E, Kasl SV, Reynolds CF, Anderson B, Zubenko GS, Houck P, George CJ, Kupfer DJ: Complicated grief and bereavement-related depression as distinct disorders: Preliminary empirical validation in elderly bereaved spouses. Am J Psychiatry 1995;152:22-30.
17. Prigerson HG, Shear MK, Jacobs SC, Reynolds CF 3rd, Maciejewski PK, Davidson JR, Rosenheck R, Pilkonis PA, Wortman CB, Williams JB, Widiger TA, Frank E, Kupfer DJ, Zisook S: Consensus criteria for traumatic grief. A preliminary empirical test. Br J Psychiatry 1999;174: 67-73.
18. Endicott J: Measurement of depression in patients with cancer. Cancer 1984;53(suppl): 2243-2248.
19. McDaniel JS, Brown FW, Cole SA: Assessment of depression and grief reactions in the medically ill; in Stoudermire A, Fogel BS, Greenberg DB (eds): Psychiatric Care of the Medical Patient, ed 2. Oxford, Oxford University Press, 2000.
20. Arolt V: Psychische Störungen bei Krankenhauspatienten. Berlin, Springer, 1997.
21. Hansen MS, Fink P, Frydenberg M, Oxhoj M, Sondergaard L, Munk-Jorgensen P: Mental disorders among internal medical inpatients: Prevalence, detection, and treatment status. J Psychosom Res 2001;50:199-204.
22. Wancata J, Windhaber J, Bach M, Meise U: Recognition of psychiatric disorders in nonpsychiatric hospital wards. J Psychosom Res 2000;48:149-155.
23. Arolt V, Driessen M, Bangert-Verleger A, Neubauer H, Schürmann A, Seibert W: Psychische Störungen bei internistischen und chirurgischen Krankenhauspatienten: Prävalenz und Behandlungsbedarf. Nervenarzt 1995;66:670-677.
24. Arolt V: Psychische Störungen bei Krankenhauspatienten. Berlin, Springer, 1997.
25. Hansen MS, Fink P, Frydenberg M, Oxhoj ML, Sondergaard L, Eriksen M: Mental disorders in medical inpatients and the association to severity of illness, self-rated physical disability, and health perception. Psychosomatics 2001;42:41-47.
26. Silverstone PH: Changes in depression scores following life-threatening illness. Psychosom Res 1990;34:659-663.
27. Arolt V, Driessen M: Alcoholism and psychiatric comorbidity in general hospital inpatients. Gen Hosp Psychiatry 1996;18:271-277.
28. Maier W, Falkai P: The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases. Int Clin Psychopharmacol 1999;14(suppl 2):1-6.
29. Mayou R, Hawton K, Feldman E: What happens to medical patients with psychiatric disorder? J Psychosom Res 1988;32:541-549.
30. Goldberg D, Lecrubier Y: Form and frequency of mental disorders across centers; in Üstün TB, Sartorius N (eds): Mental Illness in General Health Care: An International Study. Chichester, Wiley, 1995, pp 323-334.
31. Linden M, Maier W, Achberger M, Herr R, Helmchen H, Benkert O: Psychiatric diseases and their treatment in general practice in Germany. Results of a World Health Organization (WHO) study. Nervenarzt 1996;67:205-215.
32. Linden M: Psychische Störungen in der primärärztlichen Versorgung; in Helmchen H, Henn H, Lauter H, Sartorius N (eds): Psychiatrie der Gegenwart. Bd 2: Allgemeine Psychiatrie, ed 4. Berlin, Springer, 1999.
33. Kühn KU, Quednow BB, Barkow K, Heun R, Linden M, Maier W: Chronifizierung und psychosoziale Behinderung durch depressive Erkrankungen in der Allgemeinarztpraxis im Einjahresverlauf. Nervenarzt 2002;73:644-650.
34. Häfner H, Bickel H: Physical morbidity and mortality in psychiatric patients; in Öhnmann R, Freedman HL, Franck Holmquist A, Nielzen S (eds): Interaction between Mental and Physical Illness. Berlin, Springer, 1989.
35. Maddock C, Pariante CM: How does stress affect you? An overview of stress, immunity, depression and disease. Epidemiol Psychiatr Soc 2001;10:153-162.
36. Katon W, Ciechanowski P: Impact of major depression on chronic medical illness. J Psychosom Res 2002;53:859-863.
37. Herrmann-Lingen C, Klemme H, Meyer T: Depressed mood, physician-rated prognosis, and comorbidity as independent predictors of 1-year mortality in consecutive medical inpatients. J Psychosom Res 2001;50:295-301.
38. DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med 2000;160:2101-2107.
39. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH: Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int 1998;54: 245-254.
40. Carney RM, Freedland KE, Miller GE, Jaffe AS: Depression as a risk factor for cardiac mortality and morbidity - A review of potential mechanisms. J Psychosom Res 2002;53:879-902.
41. Deuschle M, Lederbogen F: Depression und koronare Herzerkrankung: Pathogenetische Faktoren vor dem Hintergrund des Stresskoncepts. Fortschr Neurol Psychiatr 2002;70:268-275.
42. Hesslinger B, Harter M, Barth J, Klecha D, Bode C, Walden J, Bengel J, Berger M: Komorbidität von depressiven Störungen und kardiovasulären Erkrankungen. Implikationen für Diagnostik, Pharmako- und Psychotherapie. Nervenarzt 2002;73:205-217.
43. Lesperance F, Frasure-Smith N: Depression in patients with cardiac disease: A practical review. J Psychosom Res 2000;48:379-391.
44. Glassman AH, Shapiro PA: Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-11.
45. Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 1998;55:580-592.
46. Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin R, Zucker HD: The nature and course of depression following myocardial infarction. Arch Intern Med 1989;149: 1785-1789.
47. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG: Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002;105:1049-1053.
48. Linden W, Stossel C, Maurice J: Psychosocial interventions for patients with coronary artery disease: A meta-analysis. Arch Intern Med 1996;156:745-752.
49. Carney RM, Freedland KE, Veith RC, Jaffe AS: Can treating depression reduce mortality after an acute myocardial infarction? Psychosom Med 1999;61:666-675.
50. Louis AA, Manousos IR, Coletta AP, Clark AL, Cleland JG: Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Impact Of Nicorandil on Angina. Combination Assessment of Ranolazine In Stable Angina. ENhancing Recovery In Coronary Heart Disease patients. Assessment of Cardioversion Using Transoesophageal Echocardiography. AzimiLide post-Infarct surVival Evaluation. Randomised Evaluation of Mechanical Assistance for Treatment of Chronic Heart failure. Eur J Heart Fail 2002;4:111-116.
51. Cossette S, Frasure-Smith N, Lesperance F: Clinical implications of a reduction in psychological distress on cardiac prognosis in patients participating in a psychosocial intervention program. Psychosom Med 2001;63:257-266.
52. Cohen HW, Gibson G, Alderman MH: Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. Am J Med 2000;108:2-8.
53. Shapiro PA, Lesperance F, Frasure-Smith N, O'Connor CM, Baker B, Jiang JW, Dorian P, Harrison W, Glassman AH: An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline anti-depressant heart attack trial. Am Heart J 1999;137:1100-1106.
54. Sauer WH, Berlin JA, Kimmel SE: Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001;104:1894-1898.
55. Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R: Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 2002;7:468-473.
56. Huff W, Steckel R, Sitzer M: 'Poststroke Depression' epidemiologie, risikofaktoren und auswirkungen auf den verlauf des schlaganfalls. Nervenarzt 2003;74:104-114.
57. Whyte EM, Mulsant BH: Post stroke depression: Epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 2002;52:253-264.
58. Quimet MA, Primeau F, Cole MG: Psychosocial risk factors in poststroke depression: A systematic review. Can J Psychiatry 2001;46:819-828.
59. Massie MJ, Holland JC: Depression and the cancer patient. J Clin Psychiatry 1990;51(suppl):12-17.
60. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB: Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry 1995;52:89-99.
61. Dalton SO, Mellemkjaer L, Olsen JH, Mortensen PB, Johansen C: Depression and cancer risk: A register-based study of patients hospitalized with affective disorders, Denmark, 1969-1993. Am J Epidemiol 2002;155:1088-1095.
62. Fox BH: Psychosocial factors in cancer incidence and prognosis; in Holland JC (ed): Psychooncology. New York, Oxford University Press, 1998.
63. Tschuschke V: Psychoonkologie. Berlin, Schattauer, 2002.
64. Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jorgensen T: Depression as a prognostic factor for breast cancer mortality. Psychosomatics 2003;44:24-30.
65. Newport DJ, Nemeroff CB: Assessment and treatment of depression in the cancer patient. J Psychosom Res 1998;45:215-237.
66. Spiegel D: Effects of psychotherapy on cancer survival. Natl Rev Cancer 2002;2:383-389.
67. Cummings JL: Depression in Parkinson's disease: A review. Am J Psychiatry 1992;149:443-454.
68. Okun MS, Watts RL: Depression associated with Parkinson's disease - Clinical features and treatment. Neurology 2002;58:63-70.
69. Nilsson FM, Kessing LV, Sorensen TM, Andersen PK, Bolwig TG: Major depressive disorder in Parkinson's disease: A register-based study. Acta Psychiatr Scand 2002;106:202-211.
70. Mayeux R: The 'serotonin hypothesis' for depression in Parkinson's disease. Adv Neurol 1990;53: 163-166.
71. Tandberg E, Larsen JP, Aarsland D, Laake K, Cummings JL: Risk factors for depression in Parkinson disease. Arch Neurol 1997;54:625-630.
72. Lemke MR, Raethjen J: Depression und Morbus Parkinson. Klinik, Diagnose, Therapie. Bremen, Uni-Med, 2002.
73. Aarsland D, Cummings JL: Depression in Parkinson's disease. Acta Psychiatr Scand 2002; 106:161-162.
74. Zesiewicz TA, Gold M, Chari G, Hauser RA: Current issues in depression in Parkinson's disease. Am J Geriatr Psychiatry 1999;7:110-118.
75. Daniele A, Albanese A, Contarino MF, Zinzi P, Barbier A, Gasparini F, Romito LM, Bentivoglio AR, Scerrati M: Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2003;74:175-182.
76. Folkerts H: Elektrokrampftherapie bei neurologischen Erkrankungen. Nervenarzt 1995;66: 241-251.
77. Ciesla JA, Roberts JE: Meta-analysis of the relationship between HIV infection and risk for depressive disorder. Am J Psychiatry 2001;158:725-730.
78. Treisman G, Fishman M, Schwartz J, Hutton H, Lyketsos C: Mood disorders in HIV infection. Depress Anxiety 1998;7:178-187.
79. Page-Schafer K, Delorenze GN, Satariano WA, Winkelstein W: Comorbidity and survival in HIV- infected men in the San Francisco Men's Health Survey. Ann Epidemiol 1996;6:420-430.
80. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J, HIV Epidemiology Research Study Group: Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001;285:1466-1474.
81. Elliott AJ, Roy-Byrne PP: Major depressive disorder and HIV-1 infection: A review of treatment trials. Semin Clin Neuropsychiatry 1998;3:137-150.
82. Baker F, Marcellus D, Zabora J, Polland A, Jodrey D: Psychological distress among adult patients being evaluated for bone marrow transplantation. Psychosomatics 1997;38:10-19.
83. Wettergren L, Languis A, Bjorkholm M, Bjorvell H: Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation - A prospective study. Bone Marrow Transplant 1997;20:497-502.
84. Schweigkofler H, Sperner-Unterweger B, Kopp M, Trojer-Zeidler M, Holzner B: Psychiatric problems in bone marrow transplantation patients during isolation. Nervenarzt 1996;67:799-804.
85. Jenkins PL, Letser H, Alexander J, Whittaker J: A prospective study of psychosocial morbidity in adult bone marrow transplant recipients. Psychosomatics 1994;35:361-367.
86. Colon EA, Callies AL, Popkin MK, McGlave PB: Depressed mood and other variables related to bone marrow transplantation survival in acute leukemia. Psychosomatics 1991;32:420-425.
87. Mundy EA, Blanchard EB, Cirenza E, Gargiulo J, Maloy B, Blanchard CG: Posttraumatic stress disorder in breast cancer patients following autologous bone marrow transplantation or conventional cancer treatments. Behav Res Ther 2000;38:1015-1027.
88. Crow SJ, Collins J, Justic M, Goetz R, Adler S: Psychopathology following cardioverter defibrillator implantation. Psychosomatics 1998;39:305-310.
89. Klimke A, von Wilmsdorff M: Medikamentöse Behandlung - psychotrope Nebenwirkungen von Nichtpsychopharmaka; in Arolt V, Diefenbacher A (eds): Psychiatrie in der klinischen Medizin. Darmstadt, Steinkopff, 2004, pp 160-172.
90. Kasper S, Jung B: Psychiatrisch relevante Nebenwirkungen der nichtpsychopharmakologischen Pharmakotherapie Nervenarzt 1995;66:649-661.
91. Bonaccorso S, Marino V, Biondi M, Grimaldi F, Ippoliti F, Maes M: Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J Affect Disord 2002;72:237-241.
92. Horikawa N, Yamazaki T, Izumi N, Uchihara M: Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: A prospective study. Gen Hosp Psychiatry 2003;25:34-38.
93. Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH: Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002;26:643-652.
94. Pollmächer T, Haack M, Schuld A, Reichenberg A, Yirmiya R: Low levels of circulating inflammatory cytokines - Do they affect human brain functions? Brain Behav Immun 2002;16:525-532.
95. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T: Cytokineassociated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001;58:445-452.
96. van West D, Maes M: Activation of the inflammatory response system: A new look at the etiopathogenesis of major depression. Neuroendocrinol Lett 1999;20:11-17.
97. Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, Kirchner H: Inflammatory markers in major depression and melancholia. J Affect Disord 2001;63:93-102.
98. Rothermundt M, Arolt V, Fenker J, Gutbrodt H, Peters M, Kirchner H: Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci 2001; 251:90-97.
99. Mackenzie TB, Popkin MK: Suicide in the medical patient. Int J Psychiatry Med 1987;17:3-22.
100. Breitbart W, Chochinov HM, Passik SD: Psychiatric aspects of palliative care; in Doyle D, Hanks GWC, MacDonald N (eds): The Oxford Textbook of Palliative Medicine, ed 2. Oxford, Oxford University Press, 1999, pp 933-956.
101. Kleespies PM, Hughes DH, Gallacher FP: Suicide in the medically and terminally ill: Psychological and ethical considerations. J Clin Psychol 2000;58:1153-1171.
102. Akechi T, Okamura H, Yamawaki S, Uchitomi Y: Why do some cancer patients with depression desire an early death and others do not? Psychosomatics 2001;42:141-145.